Role of 18F-FDG PET/CT in Assessment of Recurrence and Metastases in Female Breast Carcinoma Patients in Relation to Immunohistochemical Markers: Emphasis on HER2 Status, SUVmax Correlation, and Alignment with 2025/2026 EANM/SNMMI Guidelines. Bangladesh J. Nuclear Med. 2026;29(1):28-35. doi:10.3329/bjnm.v29i1.89278